Emily Leproust, Twist Bioscience CEO

Twist Bio­science’s 'fac­to­ry of the fu­ture' in Ore­gon could de­liv­er with com­pet­i­tive pric­ing, SVB Se­cu­ri­ties says

The syn­thet­ic DNA man­u­fac­tur­er Twist Bio­science has giv­en a peek be­hind the cur­tain to sev­er­al an­a­lysts in­to its “fac­to­ry of the fu­ture” as well as in­sight in­to the cost struc­ture, work­flow and tech­nol­o­gy at the site.

The 110,000-square-foot man­u­fac­tur­ing site in the city of Wilsonville, OR, just south of Port­land, which was an­nounced back in 2020, will dou­ble Twist’s pro­duc­tion ca­pac­i­ty and bring around 400 jobs to the area.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.